Axol Bioscience

Axol Bioscience is the leading provider of human iPSC-based products and services, to build more relevant models of human disease that expand understanding and de-risk drug development. We support researchers and the biopharma industry with three main offerings: a commercial library of 70 human iPSCs (axoLines™); iPSC-derived cells (axoCells™); and custom research capabilities (axoServices™) comprising gene editing, electrophysiology, reprogramming and differentiation.

At Axol, we've built a reputation for quality and consistency, manufacturing our products under stringent ISO 9001:2015 quality measures with robust scientific expertise and functional data. With over a decade of scientific expertise, a strong company culture and a global network of collaborators, we've become the industry leaders in using human iPSCs to drive better human disease models.